Improving Mood with Psychoanalytic and Cognitive Therapies (IMPACT)

  • Research Project Team

    • Professor Peter Fonagy,
    • Dr Rob Senior,
    • Professor Mary Target,
    • Dr Nick Midgley,
    • Professor Ian Goodyer,
    • Dr Sally O'Keeffe


    • University of Cambridge,
    • University of Manchester,
    • University College London


  • Background

    In the UK, 1 in 10 young people referred to Child and Adolescent Mental Health Services (CAMHS) receives a diagnosis of depression. There are strong links between adolescent depression and recurrent depressive episodes and suicidality in later life.

    This highlights the need to identify psychological treatments that have long-term benefits in reducing the risk of relapse in later life.

    In 2005, the NICE guidelines highlighted the need for a randomised controlled trial (RCT) to assess the efficacy of Cognitive Behavioural Therapy (CBT) and psychodynamic psychotherapy in the treatment of adolescent depression.

    The IMPACT trial was set up in response to NICE recommendations, and is the largest clinical trial of psychological therapies for adolescent depression ever to have taken place in Europe.

  • Aims

    • To assess the effectiveness of three therapeutic interventions in the treatment and relapse prevention of adolescent depression.

    • To estimate the overall health, social and educational costs of the interventions based on research findings, and build ground for future adolescent depression treatment recommendations.

    • To explore whether, or how, cortisol levels and genes might influence individual responses to treatment.
  • Methodology

    The study was a pragmatic randomised controlled trial, to reflect how services are provided, and used, in real NHS settings by the adolescent population.

    470 participants aged 11-17 years with moderate/severe depression were recruited from CAMHS within NHS Trusts across three regions in the UK: North London, East Anglia and the North West.

    Participants were randomly allocated to one of the three interventions: Cognitive Behavioural Therapy (CBT), Short Term Psychoanalytic Psychotherapy (STPP) and a Brief Psychosocial Intervention (BPI). Outcome assessments took place with participants at 6, 12, 36, 52 and 86 weeks after starting treatment.

  • Results

    Young people in all three arms of the study were found to have sustained reduced depressive symptoms at 86 week follow-up. The three treatments were found to be equally effective in maintaining reduced depressive symptoms, with an average of 49-52% reductive in depressive symptoms one year after the end of treatment. There were no significant differences in the total costs of the three treatment groups by the end of the study.


Senior Mental Health Lead training: New dates live

Sign up with the Anna Freud Centre, the UK’s leading mentally healthy schools charity.

DfE grant funding is available to cover the cost of our Senior Mental Health Lead training.

Find out more

Our use of cookies

We use necessary cookies to make our site work. We’d also like to set optional analytics to help us improve it. We won’t set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences.

For more detailed information about the cookies we use, see our Cookies page

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set non-essential cookies, such as Google Analytics, to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies page. If you are 16 or under, please ask a parent or carer for consent before accepting.